Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Abastado, J"'
Autor:
Kvist, S., Bregegere, F., Rask, L., Cami, B., Garoff, H., Daniel, F., Wiman, K., Larhammar, D., Abastado, J. P., Gachelin, G., Peterson, P. A., Dobberstein, B., Kourilsky, P.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1981 May 01. 78(5), 2772-2776.
Externí odkaz:
https://www.jstor.org/stable/10700
Publikováno v:
Cancer Cell International, Vol 4, Iss Suppl 1, p S52 (2004)
Externí odkaz:
https://doaj.org/article/642daa2308a94ac68a2cf4e2a98569f4
Autor:
Toh, B.1, Abastado, J. P.1 abastado@immunol.a-star.edu.sg
Publikováno v:
Ecancermedicalscience. 2012, Vol. 6, Special section p1-5. 5p.
Autor:
Galluzzi, L, Vacchelli, E, Bravo-San Pedro, J, Buqué, A, Senovilla, L, Baracco, E, Bloy, N, Castoldi, F, Abastado, J, Agostinis, P, Apte, R, Aranda, F, Ayyoub, M, Beckhove, P, Blay, J, Bracci, L, Caignard, A, Castelli, C, Cavallo, F, Celis, E, Cerundolo, V, Clayton, A, Colombo, M, Coussens, L, Dhodapkar, M
During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::9c0580f0009c6a1f0ab2951805b95028
https://ora.ox.ac.uk/objects/uuid:19a752ac-4056-4845-8863-3c25c05fb9af
https://ora.ox.ac.uk/objects/uuid:19a752ac-4056-4845-8863-3c25c05fb9af
Autor:
Chew, V, Chen, J, Lee, D, Lim, K H, Weber, A, Slankamenac, K, Poon, R T P, Yang, H, Ooi, L L P J, Toh, H C, Heikenwälder, M, Ng, I O L, Nardin, A, Abastado, J P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______885::71d1913e7e0985e77a9bda5e2749e7fa
https://www.zora.uzh.ch/id/eprint/49884/
https://www.zora.uzh.ch/id/eprint/49884/
Publikováno v:
European Journal of Immunology
European Journal of Immunology, 1999, 29 (5), pp.1571-80. ⟨10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-X⟩
European Journal of Immunology, Wiley-VCH Verlag, 1999, 29 (5), pp.1571-80. ⟨10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-X⟩
European Journal of Immunology, 1999, 29 (5), pp.1571-80. ⟨10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-X⟩
European Journal of Immunology, Wiley-VCH Verlag, 1999, 29 (5), pp.1571-80. ⟨10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-X⟩
International audience; The Urtica dioica agglutinin (UDA) shares with the superantigens the property of activating T cell subsets bearing particular Vbeta segments of the TCR. However, UDA is a lectin capable of binding to many glycoproteins on cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3faeb6bc9c622e49b93a7ff5ddd2c845
https://pubmed.ncbi.nlm.nih.gov/10359111
https://pubmed.ncbi.nlm.nih.gov/10359111
Autor:
Feuerbach, D., Etteldorf, S., Ebenau-Jehle, C., Abastado, J. -P, Madden, D., Hans-Gerhard Burgert
Publikováno v:
Journal of Immunology
Scopus-Elsevier
Scopus-Elsevier
The E3/19K protein of human adenovirus type 2 binds to class I MHC Ags thereby interfering with their cell surface expression and Ag presentation function. Currently, it is unclear exactly which structure of MHC molecules is recognized by the E3/19K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4736017bfb8e2394aed2027875b1979
http://www.jimmunol.org/cgi/content/abstract/153/4/1626
http://www.jimmunol.org/cgi/content/abstract/153/4/1626
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
2011 Defense Science Research Conference & Expo (DSR); 2011, p1-4, 4p